| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.4M | +378.2% |
| R&D Expense | $38.8M | +30.7% |
| SG&A Expense | $17.6M | +23.6% |
| Operating Income | -$56.3M | -29.1% |
| Pre-tax Income | -$55.3M | -27.0% |
| Income Tax | $13K | — |
| Net Income | -$55.3M | -27.0% |
| EPS (Basic) | -$1.83 | +45.4% |
| EPS (Diluted) | -$1.83 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $32.5M | -28.8% |
| Short-term Investments | $65.3M | — |
| Current Assets | $100.8M | +110.4% |
| Total Assets | $110.0M | +100.4% |
| Current Liabilities | $14.5M | -20.7% |
| Total Liabilities | $29.2M | +42.2% |
| Stockholders' Equity | $80.8M | +135.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$43.4M | -68.0% |
| Capital Expenditures | $164K | -95.2% |
| Investing Cash Flow | -$65.0M | -1820.4% |
| Financing Cash Flow | $96.3M | — |
| Free Cash Flow | -$43.5M | -49.1% |
| +45.4% |